INTODNA SPÓŁKA AKCYJNA
UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
TAX ID9452213325
Rate company:
INTODNA SPÓŁKA AKCYJNA
TAX ID9452213325
KRS0000874311
Share capital100,000.00 zł
address
UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
Website
wwwintodna.comCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9452213325 
REGON
368491518
KRS
0000874311
Legal form
joint stock company
Register Address
UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
Date of registration in KRS
2020-12-31
Date of commencement of economic activity
2020-12-31
Act signature
KR.XI NS-REJ.KRS/34793/24/118/ADE
Website
WWWINTODNA.COM
Pkd codes
72.11.Z - Scientific research and development activities
01.62.Z - Service activities supporting animal husbandry
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
71.20.A - Food quality testing and analysis
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL41 1750 0012 0000 0000 4001 4969 
PL68 1750 0012 0000 0000 3853 3584 PL67 1750 0012 0000 0000 4118 7328 EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,6 | 0,4 | -0,2 | -155,8 |
Gross profit (loss) | 0,6 | 0,3 | -0,4 | -215,1 |
EBITDA | 0,6 | 0,4 | 0,6 | 32,2 |
Short time liabilities | 1,4 | 0,9 | 1,2 | 31,2 |
Other operating costs | 0 | 0 | 0 | 6372,8 |
Equity capital | 4,3 | 5,2 | 4,8 | -7,4 |
Operating profit (EBIT) | 0,5 | 0,4 | 0 | -97,8 |
Assets | 6,5 | 7,1 | 7 | -2,3 |
Net profit (loss) | 0,5 | 0,3 | -0,4 | -216,1 |
Cash | 2,5 | 3,8 | 1,8 | -52,9 |
Net income from sale | 1,4 | 1,1 | 8,3 | 661,2 |
Liabilities and provisions for liabilities | 2,2 | 2 | 2,2 | 11,2 |
Working assets | 4,7 | 5,8 | 4,9 | -14,3 |
Other income costs | 0 | 0 | 0,2 | 1146 |
Depreciation | 0 | 0 | 0,6 | 1148,3 |
% | % | % | p.p. | |
Profitability of capital | 11,6 | 6,4 | -8 | -14,4 |
Equity capital to total assets | 65,7 | 72,6 | 68,8 | -3,8 |
Gross profit margin | 41,8 | 30,2 | -4,6 | -34,8 |
EBITDA Margin | 40,2 | 39,3 | 6,8 | -32,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 374 | 305 | 53 | -252 |
Current financial liquidity indicator | 3.308162212371826 | 6.302980422973633 | 4.117930889129639 | -2,2 |
Net dept to EBITDA | -2.2051026821136475 | -7.420064926147461 | -1.889086127281189 | 5,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download rtf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
NTRADE
Marcinowice
SAFEMED
KRAKÓW
OPTICAL WOJCIECH SKAWSKI
MYŚLENICE
Emprime sp. z o.o.
Sękocin Nowy
CMS Polska sp. z o.o.
Rzeszów